Related Experiment Video
Updated: Mar 24, 2026

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
[HORMONAL-GENETIC SCREENING IN PATIENTS, SUFFERING GASTRODUODENAL ULCER HEMORRHAGE]
Genetic-hormonal regulation impacts blood loss in gastroduodenal ulcers. Specific gene variations like VKORC1, particularly in women, and estrogen receptor expression may guide future therapies for ulcer hemorrhage.
Area of Science:
- Genetics
- Gastroenterology
- Endocrinology
Background:
- Genetic-hormonal regulation is crucial in gastroduodenal ulcer disease with hemorrhage.
- The clinical significance of certain compensatory steroidogenesis genes is not fully understood.
Purpose of the Study:
- To investigate the role of specific genes (ESR1, VKORC1) and estrogen receptor expression in gastroduodenal ulcer hemorrhage.
- To explore potential genetic markers for predicting hemorrhage risk and guiding therapy.
Main Methods:
- Polymerase chain reaction (PCR) and PCR-restriction fragment length polymorphism (PCR-RFLP) were used.
- Immunohistochemical analysis of gastroduodenal mucosa was performed on 63 patients.
Main Results:
- No significant gender-based difference in ESR1 and VKORC1 gene distribution was found, except for VKORC1 genotype A/A, which was more prevalent in women (p < 0.05).
- Gastric fundus showed immunoreactivity to alpha-estrogen receptors in epithelial and stromal cells.
Conclusions:
- Polymorphic gene VKORC1 and estrogen receptor expression are potential targets for pathogenetic therapy in patients experiencing hemorrhage.
- Understanding these genetic factors may improve management of complicated gastroduodenal ulcer disease.
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...

